The National Human Genome Research Institute (NHGRI) awarded a $1,050,000 Cooperative Agreement under the Human Genome Research program (CFDA 93.172) to the University of North Carolina at Chapel Hill (UNC-CH) to support three biennial conferences of the Ethical, Legal, and Social Implications (ELSI) Research Program between 2026 and 2030. The conferences aim to expand the reach of ELSI research to new generations, communities, and disciplines, and utilize innovative horizon scanning methods...
The National Human Genome Research Institute (NHGRI) awarded a $579,698 Project Grant (CFDA 93.172 - Human Genome Research) to the Fred Hutchinson Cancer Center in Seattle, Washington to develop the "FACETING GEMS (Genomic Education Modules) for the Entry-Level Workforce" program. The program aims to address the gap in genomics education at under-resourced community colleges by: 1) Providing accessible, research-focused genomics training modules; 2) Training and motivating partner site...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...
The National Human Genome Research Institute (NHGRI) awarded a $1,711,422 Project Grant (CFDA 93.172 - Human Genome Research) to the New York Genome Center, Inc. (NYGC) on September 23, 2024. The goal of this project is to develop a suite of privacy-preserving tools for transcriptomic data analysis, including methods for quantifying bulk and single-cell gene expression, as well as performing expression quantitative trait locus (eQTL) mapping on encrypted genotypes. This will enable large-scale...
The National Human Genome Research Institute (NHGRI) awarded a $470,250 Project Grant (CFDA 93.172 - Human Genome Research) to Children's Hospital Los Angeles (CHLA) to explore the perspectives of diverse parents on issues related to pediatric genome testing, research, and data management. The award will fund a qualitative pilot study utilizing focus groups, interviews, and a survey to: (1) examine attitudes towards genome sequencing for clinical testing and research with a focus on...
The National Human Genome Research Institute (NHGRI) awarded a $486,000 Project Grant (CFDA 93.172 - Human Genome Research) to The Johns Hopkins University to develop a Genomic Medicine Master of Science (M.S.) degree program. The program will provide advanced training to prepare health professionals and trainees with the knowledge and skills required to manipulate, annotate, and interpret human genome data, as well as a foundation for pursuing genomics research. The project leverages the...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $384,418 Project Grant to Xgenomes Corp. on September 25, 2024 to develop a revolutionary DNA sequencing platform. The project aims to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual nucleotides, enabling one or more orders of magnitude improvements in accuracy and cost over...
The National Human Genome Research Institute (NHGRI) awarded a $812,957 Project Grant under the Human Genome Research program (CFDA 93.172) to The University of Texas Southwestern Medical Center in Dallas, TX. The grant, with a project period from January 1, 2025 to December 31, 2029, aims to develop a framework of principles to provide practical guidance on variant reinterpretation, reclassification, and recontact in the evolving field of genomic medicine. The project involves qualitative...
This federal Cooperative Agreement award from the National Human Genome Research Institute (NHGRI) under the "Human Genome Research" program (CFDA 93.172) provides $666,227 to Meharry Medical College to establish a Diversity Center for Genome Research (DCGR). The goal of the DCGR is to narrow inequitable representation gaps for underrepresented minority (URM) groups in genomics research by building infrastructure, forming interdisciplinary research teams, and promoting community...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support the development of a one-year Master of Science (MS) program in Genomic Medicine for UCSF medical students. The $485,847 award, with a period of performance from September 2024 to August 2027, will fund the creation of innovative educational strategies and course content to train future physicians in the clinical applications of genetics and genomics. Key focus areas will...
The Global Genomic Medicine Collaborative (G2Mc) received a $109,050 project grant from the National Institutes of Health National Human Genome Research Institute to support its 6th International Conference on Genomic Medicine Implementation in Low Resource Settings. The conference will be held in September-October 2021 in Santiago, Chile and aims to bring together leaders in genomic medicine to discuss best practices for implementing genomics into diverse healthcare delivery systems. A hybrid in-person and virtual format is planned due to the ongoing COVID-19 pandemic. The grant will support the conference agenda focusing on facilitating understanding of implementation strategies and advancing early career investigators from lower- and middle-income countries in Latin America through mentorship opportunities. The funding assists the Human Genome Research program goal of accelerating genomic research and its clinical application.